FIELD: medicine.
SUBSTANCE: group of inventions relates to the field of medicine, namely to an immunobiological agent for the treatment of inflammatory bowel diseases containing component 1, which is a means in the form of sodium butyrate packed inside particles from a copolymer of lactic and glycolic acids, and component 2, which is a means in the form of butyrate-synthesizing bacteria, and also relates to the method for use an immunobiological agent for the treatment of inflammatory bowel diseases by oral administration of its components in an effective amount.
EFFECT: group of inventions provides a safe immunobiological agent for the treatment of inflammatory bowel diseases based on sodium butyrate, which ensures the delivery of the active substance to the intestine, as well as providing a prolonged effect.
4 cl, 8 dwg, 2 tbl, 9 ex
Authors
Dates
2022-10-04—Published
2021-12-23—Filed